CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 85 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $198,319,737 | +66.0% | 5,161,888 | 0.0% | 34.81% | +40.9% |
| Q1 2023 | $119,497,707 | -11.6% | 5,161,888 | 0.0% | 24.70% | -15.1% |
| Q4 2022 | $135,241,466 | +33.3% | 5,161,888 | 0.0% | 29.11% | +23.0% |
| Q3 2022 | $101,483,000 | +12.4% | 5,161,888 | 0.0% | 23.66% | -1.7% |
| Q2 2022 | $90,281,000 | +20.2% | 5,161,888 | +12.4% | 24.07% | +27.2% |
| Q1 2022 | $75,123,000 | +0.3% | 4,591,888 | 0.0% | 18.91% | +30.2% |
| Q4 2021 | $74,894,000 | +73.8% | 4,591,888 | +36.0% | 14.53% | +114.9% |
| Q3 2021 | $43,089,000 | -3.7% | 3,376,888 | +6.6% | 6.76% | +22.4% |
| Q2 2021 | $44,738,000 | -9.1% | 3,168,388 | 0.0% | 5.52% | -39.2% |
| Q1 2021 | $49,237,000 | -2.0% | 3,168,388 | 0.0% | 9.08% | +79.7% |
| Q4 2020 | $50,251,000 | – | 3,168,388 | – | 5.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |